UTIPRO PLUS® launched in Finland

We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Finland. The product is commercialized over the Finnish territory under the umbrella brand UrinCUR / Utipro plus and it is distributed by RFSU, our partner for the product on the Swedish and Norwegian territory as well.

Utipro® Plus is a medical device intended for the control and prevention of uncomplicated urinary tract infections produced by pathogens such as E.coli and other gram (-) bacteria normally involved in the etiology of urological infections.

The product has been available as capsules for oral administration in pharmacies and drug stores all across Finland from Q2 2020.

Utipro® Plus is a class III medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments. (CE 0373, Noventure SL).

We wish to our Partner to repeat in Finland the success already achieved in Sweden and Norway and we hope to come back soon with other good news on our product.